Erschienen in:
01.10.2006 | Current Status
Efficacy of Oral Anticancer Agents for Colorectal Cancer
verfasst von:
Junichi Sakamoto, M.D., Ph.D., Koji Oba, M.S., Takanori Matsui, M.D., Ph.D., Michiya Kobayashi, M.D., Ph.D.
Erschienen in:
Diseases of the Colon & Rectum
|
Sonderheft 1/2006
Einloggen, um Zugang zu erhalten
Excerpt
Development of oral anticancer agents was long awaited by both physicians and patients. It can be taken for granted that most patients prefer oral intake to injection of such drugs if the efficacy of the former is equivalent or superior to that of parenteral agents.
1 In terms of quality of life and cost-effectiveness, oral agents are obviously superior to parenteral drugs, which necessitate hospitalization or a long stay in the outpatient ward for their injection. …